Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Arnie Aldridge

Dados Biográficos

ID5536684
NOMEArnie Aldridge
PRENOMESArnie
SOBRENOMEAldridge
ASSINATURAALDRIDGE A
AFILIAÇÕESRTI International
ORCID0000-0003-4513-470X
VERIFICADOSim
TOTAL DE OBRAS9
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR9
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2009
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0
  • Use of fentanyl test strips by people who inject drugs

    Open Access•Erin Erickson, Arnie Aldridge et al.•ARTICLE•International Journal of Drug…•2026

  • Overdose education and naloxone distribution in jails

    Open Access•Timothy Hunt, Carrie B Oser et al.•ARTICLE•Health & Justice•2025

    BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…

  • The effectiveness of the communities that Heal intervention on reducing non-fatal opioid overdoses

    Open Access•Louisa Gilbert, Rouba Chahine et al.•ARTICLE•International Journal of Drug…•2025

  • Use of fentanyl test strips by people who inject drugs

    Open Access•Jon Zibbell, Arnie Aldridge et al.•ARTICLE•International Journal of Drug…•2024

    Declines in FTS use are consistent with what syringe services programs have been signaling for years. Needs assessments to gauge interest in FTS before scaling up can help ensure funding better spent on naloxone and syringes is not allocated to idle FTS. Increased FTS among women and racial minorities presents opportunities for tailored interventions. Recognizing trauma associated with witnessing overdoses as a growing component of the opioid epi…

  • Individual and Community Social Determinants of Health and Recovery from Alcohol Use Disorder Three Years following Treatment

    Open Access•Julia E Swan, Arnie Aldridge et al.•ARTICLE•Journal of Psychoactive Drugs•2021

    Prior research on recovery from alcohol use disorder (AUD) has often focused on individual-level factors that promote recovery. Given systemic health inequities, it is also important to study community-level social determinants of health (SDOH) that may promote recovery from AUD. This study extended prior work examining individual profiles of recovery from AUD to assess how individual and community SDOH at the time of treatment entry were associa…

  • Screening, Brief Intervention, and Referral to Treatment in the Emergency Department

    Janice L Pringle, David Kelley et al.•ARTICLE•Medical Care•2018•Referências: 19

    BACKGROUND: There is increasing interest in deploying screening, brief intervention, and referral to treatment (SBIRT) practices in emergency departments (ED) to intervene with patients at risk for substance use disorders. However, the current literature is inconclusive on whether SBIRT practices are effective in reducing costs and utilization. OBJECTIVE: This study sought to evaluate the health care costs and health care utilization associated w…

  • The Impact of a Mandated Trauma Center Alcohol Intervention on Readmission and Cost per Readmission in Arizona

    Jesse M Hinde, Jeremy W Bray et al.•ARTICLE•Medical Care•2015•Referências: 16

    BACKGROUND: Persons appearing in trauma centers have a higher prevalence of unhealthy alcohol use than the general population. Screening and brief intervention (SBI) is designed to moderate drinking levels and avoid costly future readmissions, but few studies have examined the impact of SBI on hospital readmissions and health care costs in a trauma population. RESEARCH DESIGN: This study uses comparative interrupted time-series and the Arizona St…

  • The Effect of Alcohol Treatment on Social Costs of Alcohol Dependence

    Gary A Zarkin, Jeremy W Bray et al.•ARTICLE•Medical Care•2010•Referências: 18

    BACKGROUND: The COMBINE (combined pharmacotherapies and behavioral intervention) clinical trial recently evaluated the efficacy of pharmacotherapies, behavioral therapies, and their combinations for the treatment of alcohol dependence. Previously, the cost and cost-effectiveness of COMBINE have been studied. Policy makers, patients, and nonalcohol-dependent individuals may be concerned not only with alcohol treatment costs but also with the effec…

  • Improving Data Quality in Large-Scale, Performance-Based Program Evaluations

    M L Aldridge, K D Kramer et al.•ARTICLE•American Journal of Evaluation•2009

Sem obras proeminentes nesta página.

  • Improving Data Quality in Large-Scale, Performance-Based Program Evaluations

    M L Aldridge, K D Kramer et al.•ARTICLE•American Journal of Evaluation•2009

  • The Effect of Alcohol Treatment on Social Costs of Alcohol Dependence

    Gary A Zarkin, Jeremy W Bray et al.•ARTICLE•Medical Care•2010•Referências: 18

    BACKGROUND: The COMBINE (combined pharmacotherapies and behavioral intervention) clinical trial recently evaluated the efficacy of pharmacotherapies, behavioral therapies, and their combinations for the treatment of alcohol dependence. Previously, the cost and cost-effectiveness of COMBINE have been studied. Policy makers, patients, and nonalcohol-dependent individuals may be concerned not only with alcohol treatment costs but also with the effec…

  • The Impact of a Mandated Trauma Center Alcohol Intervention on Readmission and Cost per Readmission in Arizona

    Jesse M Hinde, Jeremy W Bray et al.•ARTICLE•Medical Care•2015•Referências: 16

    BACKGROUND: Persons appearing in trauma centers have a higher prevalence of unhealthy alcohol use than the general population. Screening and brief intervention (SBI) is designed to moderate drinking levels and avoid costly future readmissions, but few studies have examined the impact of SBI on hospital readmissions and health care costs in a trauma population. RESEARCH DESIGN: This study uses comparative interrupted time-series and the Arizona St…

  • Screening, Brief Intervention, and Referral to Treatment in the Emergency Department

    Janice L Pringle, David Kelley et al.•ARTICLE•Medical Care•2018•Referências: 19

    BACKGROUND: There is increasing interest in deploying screening, brief intervention, and referral to treatment (SBIRT) practices in emergency departments (ED) to intervene with patients at risk for substance use disorders. However, the current literature is inconclusive on whether SBIRT practices are effective in reducing costs and utilization. OBJECTIVE: This study sought to evaluate the health care costs and health care utilization associated w…

  • Individual and Community Social Determinants of Health and Recovery from Alcohol Use Disorder Three Years following Treatment

    Open Access•Julia E Swan, Arnie Aldridge et al.•ARTICLE•Journal of Psychoactive Drugs•2021

    Prior research on recovery from alcohol use disorder (AUD) has often focused on individual-level factors that promote recovery. Given systemic health inequities, it is also important to study community-level social determinants of health (SDOH) that may promote recovery from AUD. This study extended prior work examining individual profiles of recovery from AUD to assess how individual and community SDOH at the time of treatment entry were associa…

  • Use of fentanyl test strips by people who inject drugs

    Open Access•Jon Zibbell, Arnie Aldridge et al.•ARTICLE•International Journal of Drug…•2024

    Declines in FTS use are consistent with what syringe services programs have been signaling for years. Needs assessments to gauge interest in FTS before scaling up can help ensure funding better spent on naloxone and syringes is not allocated to idle FTS. Increased FTS among women and racial minorities presents opportunities for tailored interventions. Recognizing trauma associated with witnessing overdoses as a growing component of the opioid epi…

  • Overdose education and naloxone distribution in jails

    Open Access•Timothy Hunt, Carrie B Oser et al.•ARTICLE•Health & Justice•2025

    BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…

  • The effectiveness of the communities that Heal intervention on reducing non-fatal opioid overdoses

    Open Access•Louisa Gilbert, Rouba Chahine et al.•ARTICLE•International Journal of Drug…•2025

  • Use of fentanyl test strips by people who inject drugs

    Open Access•Erin Erickson, Arnie Aldridge et al.•ARTICLE•International Journal of Drug…•2026

Medicine (7 obras) · Opioid Use Disorder Treatment (6 obras) · Substance Abuse Treatment and Outcomes (6 obras) · Medical emergency (3 obras) · Nursing (3 obras) · Psychology (3 obras) · Alcohol (2 obras) · Computer Science (2 obras) · Emergency Medicine (2 obras) · Emergency Medicine (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae